Amyris Biotechnologies has raised $41.75 million as part of a C
round to fund the commercialization of the company's biofuel and
chemicals in 2011.  The Emeryville, Calif.-based startup began
raising the round this summer, and it aims to raise
"approximately $60 million."  Amyris was able to raise the
first, $24.7 million by August (the date of first sale was July
31), according to its filing with the U.S. Securities and
Exchange Commission. The filing said the company was seeking to
raise $62 million.  New investors for the round included
GrupoCornelioBrennand in Brazil and Naxos in the United Kingdom,
Amyris said. Earlier investors Khosla Ventures, Kleiner Perkins
Caufield & Byers, TPG Biotech and Votorantim Novos Negocios also
put in money this time.  If Amyris successfully closes a C round
of $60 million, then it will have raised a total of about $165
million in equity since its inception in 2003, the company said
in a press release Thursday. However, a company's press release
in June this year said it al